SMTL ID : 8yqd.1

Crystal structure of human transthyretin variant A97S in complex with Tafamidis

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

homo-dimer

Ligands

2 x 3MI: 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid(Non-covalent)

3MI.1: 6 residues within 4Å: Chain A: K.15, L.17, A.108, S.117, T.118, T.119 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:K.15, A:K.15 Water bridges: A:K.15, A:K.15 Salt bridges: A:K.15 3MI.2: 8 residues within 4Å: Chain B: K.15, L.17, T.106, A.108, L.110, S.117, T.118, T.119 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:K.15, B:L.110 Salt bridges: B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chao, C.C. et al., Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis. Ann Clin Transl Neurol (2024)

Release Date

2025-01-29

Peptides

Transthyretin: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Transthyretin